United States · FDA National Drug Code directory
Tadalafil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-551_f7f0bf23-1272-256a-e053-6294a90a40ee
- Product NDC
- 76420-551
- Form
- TABLET
- Composition / generic term
- Tadalafil
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190326
- Source listing expiry
- 20261231
Source-listed ingredients
- TADALAFIL — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (76420-551-05) · 76420-551-05
- 120 TABLET in 1 BOTTLE (76420-551-12) · 76420-551-12
- 30 TABLET in 1 BOTTLE (76420-551-30) · 76420-551-30
- 60 TABLET in 1 BOTTLE (76420-551-60) · 76420-551-60
- 90 TABLET in 1 BOTTLE (76420-551-90) · 76420-551-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →